RE:RE:Holding the lineROFLMAO, a high bet?
The biggest thing to ever happend with this company, FDA approval, and it is trading about where we were May 24.
Markets are forward looking and have already included the 70% cash from the voucher.
Ask yourself Stups, why has the market not done the $50 CDN you predicted.
Two weeks before PDUFA date, LMNL sells 30% for peanuts. Five million to be exact and LMNL threw in the plasma product line, including the just approved Ryplazim. Wasn't Ryplazim their only revenue stream?
They also sold the two plasma collection centers for $17M. Why not, they no longer have an FDA aprroved product.
That is why the "HIGH BETA" stock has not moved. Investors with half a brain can see SH just go screwed a second time. Who would want to waste money with them.
Newcamo wrote: this is high beta, u can trade the swings, once they cash in the more or less 100M$ it will swing north hard.... u can trade for this short term, or buy here and hold for next partnership. It moved hard on the FDA news, it will do it again on the cash inflow from the voucher. Whatever the strategy, there is no risk buying here, and at least go for the swing on the cash inflow (100M$).
inventors wrote: The sp is trending down, but supports may hold near the 50 moving day average.
The PSAR is near $4.12, the 50 MDA $4.42, and biotech season starts June 23...